![](https://monteverdelaw.com/wp-content/uploads/case-logo/nextgen-healthcare-inc.png)
NextGen Healthcare, Inc. (Nasdaq: NXGN), relating to its proposed sale to Thoma Bravo. Under the terms of the agreement, NXGN shareholders are expected to receive $23.95 in cash per share they own.
NextGen Healthcare, Inc. (Nasdaq: NXGN), relating to its proposed sale to Thoma Bravo. Under the terms of the agreement, NXGN shareholders are expected to receive $23.95 in cash per share they own.